Sector
Epigenetic Reprogramming
Discover the early-stage Epigenetic Reprogramming ecosystem: investors, accelerators, incubators, fellowships, grants, and global hubs powering next-gen Epigenetic Reprogramming startups.
Discover the early-stage Epigenetic Reprogramming ecosystem: investors, accelerators, incubators, fellowships, grants, and global hubs powering next-gen Epigenetic Reprogramming startups.
Scouts
Share promising startups in this sector and get rewarded if they raise. No prior track record needed.
Investors
Access qualified startups curated by Superscout across pre-seed to seed.
Supporters
Work at a company, lab, or city? Connect with builders in your space.
Epigenetic reprogramming reverses cellular age by resetting epigenetic marks (DNA methylation, histone modifications) that accumulate and deteriorate with aging. The approach, based on Shinya Yamanaka's Nobel Prize-winning discovery of induced pluripotent stem cells, is the most ambitious therapeutic approach in longevity science, with companies pursuing partial reprogramming that reverses cellular age without losing cell identity.
